Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | rheumatoid arthritis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:23143596 | |
|
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | rheumatoid arthritis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:23143596 | |
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:8125298 | PMID:11470852 | PMID:12477932 | PMID:16189514 | PMID:16344560 | PMID:20379614 | PMID:24623722 | PMID:25925205 | PMID:32235678 | PMID:32393512 | PMID:33961781 | PMID:35256949 |
GIN1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gin1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gin1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gin1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GIN1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GIN1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gin1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GIN1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GIN1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gin1 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in GIN1
25 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 5q13.3-22.1(chr5:74163186-110809453)x3 | copy number gain | See cases [RCV000051839] | Chr5:74163186..110809453 [GRCh38] Chr5:73459011..110145153 [GRCh37] Chr5:73494767..110173052 [NCBI36] Chr5:5q13.3-22.1 |
pathogenic |
GRCh38/hg38 5q15-22.3(chr5:96454445-114050905)x3 | copy number gain | See cases [RCV000051841] | Chr5:96454445..114050905 [GRCh38] Chr5:95790149..113386602 [GRCh37] Chr5:95815905..113414501 [NCBI36] Chr5:5q15-22.3 |
pathogenic |
GRCh38/hg38 5q14.3-21.2(chr5:89081352-104687248)x1 | copy number loss | See cases [RCV000053516] | Chr5:89081352..104687248 [GRCh38] Chr5:88377169..104022949 [GRCh37] Chr5:88412925..104050848 [NCBI36] Chr5:5q14.3-21.2 |
pathogenic |
GRCh38/hg38 5q21.1-22.2(chr5:102373396-113594030)x1 | copy number loss | See cases [RCV000053523] | Chr5:102373396..113594030 [GRCh38] Chr5:101709100..112929727 [GRCh37] Chr5:101736999..112957626 [NCBI36] Chr5:5q21.1-22.2 |
pathogenic |
NM_017676.2(GIN1):c.431C>T (p.Thr144Ile) | single nucleotide variant | Malignant melanoma [RCV000061080] | Chr5:103104749 [GRCh38] Chr5:102440453 [GRCh37] Chr5:102468352 [NCBI36] Chr5:5q21.1 |
not provided |
GRCh38/hg38 5q21.1-21.2(chr5:102812129-104230720)x3 | copy number gain | See cases [RCV000138667] | Chr5:102812129..104230720 [GRCh38] Chr5:102147833..103566421 [GRCh37] Chr5:102175732..103594320 [NCBI36] Chr5:5q21.1-21.2 |
likely benign |
GRCh38/hg38 5q14.3-23.3(chr5:90374606-128076423)x1 | copy number loss | See cases [RCV000139893] | Chr5:90374606..128076423 [GRCh38] Chr5:89670423..127412115 [GRCh37] Chr5:89706179..127440014 [NCBI36] Chr5:5q14.3-23.3 |
pathogenic |
GRCh38/hg38 5q14.3-22.1(chr5:84603580-111435081)x1 | copy number loss | See cases [RCV000139656] | Chr5:84603580..111435081 [GRCh38] Chr5:83899398..110770779 [GRCh37] Chr5:83935154..110798678 [NCBI36] Chr5:5q14.3-22.1 |
pathogenic |
GRCh38/hg38 5q14.3-23.1(chr5:92899734-119614119)x1 | copy number loss | See cases [RCV000141252] | Chr5:92899734..119614119 [GRCh38] Chr5:92235441..118949814 [GRCh37] Chr5:92261197..118977713 [NCBI36] Chr5:5q14.3-23.1 |
pathogenic |
GRCh38/hg38 5q15-22.2(chr5:93193104-113287795)x1 | copy number loss | See cases [RCV000143249] | Chr5:93193104..113287795 [GRCh38] Chr5:92528810..112623492 [GRCh37] Chr5:92554566..112651391 [NCBI36] Chr5:5q15-22.2 |
pathogenic |
GRCh38/hg38 5q14.3-31.1(chr5:91411708-131319563)x1 | copy number loss | See cases [RCV000143746] | Chr5:91411708..131319563 [GRCh38] Chr5:90707525..130655256 [GRCh37] Chr5:90743281..130683155 [NCBI36] Chr5:5q14.3-31.1 |
pathogenic |
GRCh37/hg19 5q15-35.3(chr5:94844077-178830410)x3 | copy number gain | not provided [RCV000487658] | Chr5:94844077..178830410 [GRCh37] Chr5:5q15-35.3 |
likely benign |
GRCh37/hg19 5q21.1-23.2(chr5:100607918-125900735)x1 | copy number loss | See cases [RCV000445968] | Chr5:100607918..125900735 [GRCh37] Chr5:5q21.1-23.2 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789) | copy number gain | See cases [RCV000510723] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5q15-21.2(chr5:95049966-103537589)x1 | copy number loss | See cases [RCV000510548] | Chr5:95049966..103537589 [GRCh37] Chr5:5q15-21.2 |
likely pathogenic |
GRCh37/hg19 5p15.1-q35.2(chr5:17628741-176575720)x1 | copy number loss | See cases [RCV000511978] | Chr5:17628741..176575720 [GRCh37] Chr5:5p15.1-q35.2 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)x3 | copy number gain | See cases [RCV000512039] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5q21.1-21.2(chr5:98845559-103355831)x1 | copy number loss | See cases [RCV000511250] | Chr5:98845559..103355831 [GRCh37] Chr5:5q21.1-21.2 |
uncertain significance |
NC_000005.9:g.(?_86400000)_(154000000_?)del | deletion | Familial adenomatous polyposis 1 [RCV002231249]|Hereditary cancer-predisposing syndrome [RCV000554476] | Chr5:86400000..154000000 [GRCh37] Chr5:5q14.3-33.2 |
pathogenic |
GRCh37/hg19 5q21.1(chr5:102398221-102788681)x3 | copy number gain | not provided [RCV000682586] | Chr5:102398221..102788681 [GRCh37] Chr5:5q21.1 |
likely benign |
GRCh37/hg19 5q14.3-21.3(chr5:91504101-104858348)x1 | copy number loss | not provided [RCV000682580] | Chr5:91504101..104858348 [GRCh37] Chr5:5q14.3-21.3 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:25328-180693344)x3 | copy number gain | not provided [RCV000744323] | Chr5:25328..180693344 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:13648-180905029)x3 | copy number gain | not provided [RCV000744317] | Chr5:13648..180905029 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
Single allele | deletion | Neurodevelopmental disorder [RCV000787436] | Chr5:14685137..149511942 [GRCh37] Chr5:5p15.2-q32 |
uncertain significance |
GRCh37/hg19 5q14.3-23.3(chr5:89949118-129317455)x3 | copy number gain | not provided [RCV000849289] | Chr5:89949118..129317455 [GRCh37] Chr5:5q14.3-23.3 |
pathogenic |
GRCh37/hg19 5q21.1(chr5:102096690-102460794)x1 | copy number loss | not provided [RCV000846950] | Chr5:102096690..102460794 [GRCh37] Chr5:5q21.1 |
uncertain significance |
GRCh37/hg19 5q21.1-21.2(chr5:102422529-104039584)x3 | copy number gain | not provided [RCV000849385] | Chr5:102422529..104039584 [GRCh37] Chr5:5q21.1-21.2 |
uncertain significance |
GRCh37/hg19 5q21.1-21.2(chr5:101152187-103638623)x3 | copy number gain | not provided [RCV001005707] | Chr5:101152187..103638623 [GRCh37] Chr5:5q21.1-21.2 |
uncertain significance |
GRCh37/hg19 5q21.1(chr5:101620402-102584810)x3 | copy number gain | not provided [RCV001005708] | Chr5:101620402..102584810 [GRCh37] Chr5:5q21.1 |
likely benign |
NM_017676.2(GIN1):c.716C>T (p.Thr239Met) | single nucleotide variant | not provided [RCV001671382] | Chr5:103097705 [GRCh38] Chr5:102433409 [GRCh37] Chr5:5q21.1 |
benign |
GRCh37/hg19 5q14.3-21.3(chr5:87792844-109221844)x3 | copy number gain | See cases [RCV001007415] | Chr5:87792844..109221844 [GRCh37] Chr5:5q14.3-21.3 |
likely pathogenic |
GRCh37/hg19 5q21.1(chr5:102034608-102540865)x3 | copy number gain | not provided [RCV001259347] | Chr5:102034608..102540865 [GRCh37] Chr5:5q21.1 |
uncertain significance |
GRCh37/hg19 5q21.1(chr5:102096690-102460794)x1 | copy number loss | not provided [RCV001259346] | Chr5:102096690..102460794 [GRCh37] Chr5:5q21.1 |
uncertain significance |
GRCh37/hg19 5q21.1-23.2(chr5:100607918-125900735) | copy number loss | not specified [RCV002053515] | Chr5:100607918..125900735 [GRCh37] Chr5:5q21.1-23.2 |
pathogenic |
GRCh37/hg19 5q15-22.3(chr5:93650000-114969108) | copy number loss | not specified [RCV002053511] | Chr5:93650000..114969108 [GRCh37] Chr5:5q15-22.3 |
pathogenic |
NM_017676.2(GIN1):c.1196G>C (p.Ser399Thr) | single nucleotide variant | Inborn genetic diseases [RCV002777033] | Chr5:103096639 [GRCh38] Chr5:102432343 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1316G>T (p.Gly439Val) | single nucleotide variant | Inborn genetic diseases [RCV002869017] | Chr5:103088151 [GRCh38] Chr5:102423855 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1343T>C (p.Ile448Thr) | single nucleotide variant | Inborn genetic diseases [RCV002978234] | Chr5:103088124 [GRCh38] Chr5:102423828 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1342A>G (p.Ile448Val) | single nucleotide variant | Inborn genetic diseases [RCV002744466] | Chr5:103088125 [GRCh38] Chr5:102423829 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1247T>C (p.Ile416Thr) | single nucleotide variant | Inborn genetic diseases [RCV002744947] | Chr5:103096588 [GRCh38] Chr5:102432292 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.88C>T (p.Pro30Ser) | single nucleotide variant | Inborn genetic diseases [RCV002896977] | Chr5:103108620 [GRCh38] Chr5:102444324 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.69A>T (p.Glu23Asp) | single nucleotide variant | Inborn genetic diseases [RCV002719629] | Chr5:103108639 [GRCh38] Chr5:102444343 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1121G>C (p.Arg374Thr) | single nucleotide variant | Inborn genetic diseases [RCV002809402] | Chr5:103096714 [GRCh38] Chr5:102432418 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.914T>G (p.Val305Gly) | single nucleotide variant | Inborn genetic diseases [RCV003010597] | Chr5:103097408 [GRCh38] Chr5:102433112 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.662T>G (p.Leu221Trp) | single nucleotide variant | Inborn genetic diseases [RCV003202403] | Chr5:103097759 [GRCh38] Chr5:102433463 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.404A>G (p.Lys135Arg) | single nucleotide variant | Inborn genetic diseases [RCV003189547] | Chr5:103104776 [GRCh38] Chr5:102440480 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.379G>A (p.Val127Ile) | single nucleotide variant | Inborn genetic diseases [RCV003174973] | Chr5:103104801 [GRCh38] Chr5:102440505 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.389A>T (p.Lys130Ile) | single nucleotide variant | Inborn genetic diseases [RCV003177937] | Chr5:103104791 [GRCh38] Chr5:102440495 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1301T>A (p.Leu434His) | single nucleotide variant | Inborn genetic diseases [RCV003287408] | Chr5:103088166 [GRCh38] Chr5:102423870 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1454T>C (p.Leu485Pro) | single nucleotide variant | Inborn genetic diseases [RCV003358559] | Chr5:103088013 [GRCh38] Chr5:102423717 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.32A>G (p.His11Arg) | single nucleotide variant | Inborn genetic diseases [RCV003345639] | Chr5:103108676 [GRCh38] Chr5:102444380 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.525G>T (p.Leu175Phe) | single nucleotide variant | Inborn genetic diseases [RCV003350576] | Chr5:103104655 [GRCh38] Chr5:102440359 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.727C>A (p.Pro243Thr) | single nucleotide variant | Inborn genetic diseases [RCV003347356] | Chr5:103097694 [GRCh38] Chr5:102433398 [GRCh37] Chr5:5q21.1 |
uncertain significance |
NM_017676.2(GIN1):c.1022A>G (p.Asn341Ser) | single nucleotide variant | Inborn genetic diseases [RCV003362346] | Chr5:103096813 [GRCh38] Chr5:102432517 [GRCh37] Chr5:5q21.1 |
uncertain significance |
GRCh37/hg19 5q15-23.2(chr5:93828571-123711334)x1 | copy number loss | not specified [RCV003986577] | Chr5:93828571..123711334 [GRCh37] Chr5:5q15-23.2 |
pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
STS-H23482 |
|
||||||||||||||||||||||||||||||||||||||||
SGC30489 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | visual system | adipose tissue | appendage | entire extraembryonic component | pharyngeal arch | |
High | ||||||||||||||||||
Medium | 8 | 3 | 6 | 12 | 11 | 4 | 45 | 23 | 81 | 9 | 2 | 1 | 4 | |||||
Low | 2427 | 2582 | 1716 | 621 | 1580 | 462 | 4323 | 2142 | 3682 | 394 | 1379 | 1600 | 173 | 1201 | 2777 | 5 | 2 | |
Below cutoff | 4 | 404 | 4 | 3 | 353 | 3 | 23 | 51 | 7 | 2 | 4 | 3 | 7 |
RefSeq Acc Id: | ENST00000399004 ⟹ ENSP00000381970 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000507478 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000508629 ⟹ ENSP00000427162 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000511400 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000512248 ⟹ ENSP00000422960 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000513603 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000513747 ⟹ ENSP00000423031 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001317954 ⟹ NP_001304883 | ||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||
Type: | CODING | ||||||||||||||||
Position: |
|
||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_017676 ⟹ NP_060146 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NR_134299 | ||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||
Type: | NON-CODING | ||||||||||||||||
Position: |
|
||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_017009599 ⟹ XP_016865088 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_047417343 ⟹ XP_047273299 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054352864 ⟹ XP_054208839 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054352865 ⟹ XP_054208840 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_060146 ⟸ NM_017676 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q6AI03 (UniProtKB/Swiss-Prot), B4DIV4 (UniProtKB/Swiss-Prot), B2RXF7 (UniProtKB/Swiss-Prot), Q96BR2 (UniProtKB/Swiss-Prot), Q9NXP7 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001304883 ⟸ NM_001317954 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q9NXP7 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | XP_016865088 ⟸ XM_017009599 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q6AI03 (UniProtKB/Swiss-Prot), B4DIV4 (UniProtKB/Swiss-Prot), B2RXF7 (UniProtKB/Swiss-Prot), Q96BR2 (UniProtKB/Swiss-Prot), Q9NXP7 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | ENSP00000381970 ⟸ ENST00000399004 |
RefSeq Acc Id: | ENSP00000427162 ⟸ ENST00000508629 |
RefSeq Acc Id: | ENSP00000422960 ⟸ ENST00000512248 |
RefSeq Acc Id: | ENSP00000423031 ⟸ ENST00000513747 |
RefSeq Acc Id: | XP_047273299 ⟸ XM_047417343 |
- Peptide Label: | isoform X2 |
RefSeq Acc Id: | XP_054208839 ⟸ XM_054352864 |
- Peptide Label: | isoform X1 |
RefSeq Acc Id: | XP_054208840 ⟸ XM_054352865 |
- Peptide Label: | isoform X2 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q9NXP7-F1-model_v2 | AlphaFold | Q9NXP7 | 1-522 | view protein structure |
RGD ID: | 6803091 | ||||||||
Promoter ID: | HG_KWN:50765 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000274384, ENST00000321521, NM_017676, UC003KOB.1, UC003KOC.1, UC003KOD.2, UC010JBO.1 | ||||||||
Position: |
|
RGD ID: | 6870196 | ||||||||
Promoter ID: | EPDNEW_H8263 | ||||||||
Type: | initiation region | ||||||||
Name: | GIN1_1 | ||||||||
Description: | gypsy retrotransposon integrase 1 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H8264 | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6870198 | ||||||||
Promoter ID: | EPDNEW_H8264 | ||||||||
Type: | multiple initiation site | ||||||||
Name: | GIN1_2 | ||||||||
Description: | gypsy retrotransposon integrase 1 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H8263 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:25959 | AgrOrtholog |
COSMIC | GIN1 | COSMIC |
Ensembl Genes | ENSG00000145723 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000399004 | ENTREZGENE |
ENST00000399004.7 | UniProtKB/Swiss-Prot | |
ENST00000508629.5 | UniProtKB/Swiss-Prot | |
ENST00000512248.5 | UniProtKB/Swiss-Prot | |
ENST00000513747.1 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 1.10.340.70 | UniProtKB/Swiss-Prot |
3.30.420.10 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000145723 | GTEx |
HGNC ID | HGNC:25959 | ENTREZGENE |
Human Proteome Map | GIN1 | Human Proteome Map |
InterPro | Integrase_cat-core | UniProtKB/Swiss-Prot |
Integrase_H2C2 | UniProtKB/Swiss-Prot | |
RNaseH-like_sf | UniProtKB/Swiss-Prot | |
RNaseH_sf | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:54826 | UniProtKB/Swiss-Prot |
NCBI Gene | 54826 | ENTREZGENE |
PANTHER | ENDONUCLEASE-RELATED | UniProtKB/Swiss-Prot |
GYPSY RETROTRANSPOSON INTEGRASE-LIKE PROTEIN 1 | UniProtKB/Swiss-Prot | |
Pfam | Integrase_H2C2 | UniProtKB/Swiss-Prot |
rve | UniProtKB/Swiss-Prot | |
PharmGKB | PA162389674 | PharmGKB |
PROSITE | INTEGRASE | UniProtKB/Swiss-Prot |
Superfamily-SCOP | SSF53098 | UniProtKB/Swiss-Prot |
UniProt | B2RXF7 | ENTREZGENE |
B4DIV4 | ENTREZGENE | |
GIN1_HUMAN | UniProtKB/Swiss-Prot | |
Q6AI03 | ENTREZGENE | |
Q96BR2 | ENTREZGENE | |
Q9NXP7 | ENTREZGENE | |
UniProt Secondary | B2RXF7 | UniProtKB/Swiss-Prot |
B4DIV4 | UniProtKB/Swiss-Prot | |
Q6AI03 | UniProtKB/Swiss-Prot | |
Q96BR2 | UniProtKB/Swiss-Prot |